Skip to main content
SpringerLink
Log in

SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

SDZ GLC-756, a novel octahydrobenzo[g]quinoline derivative, is equipotent in displacing [3H]SCH23390 from dopamine D1 receptors and [3H]205–501 from dopamine D2 receptor binding sites. It blocks dopamine sensitive adenylate cyclase with the same potency as SCH23390, indicating antagonist properties at dopamine D1 receptors. On the other hand, SDZ GLC 756 inhibits electrically evoked acetylcholine release from rat striatal slices with the same potency as the selective dopamine D2 receptor agonist bromocriptine. This effect is blocked by spiperone suggesting that it is mediated by dopamine D2 receptor activation. The opposing action of SDZ GLC 756 on dopamine D1 and D2 receptors is also evident in vivo. SDZ GLC 756, like SCH23390, blocks apomorphine-induced rearing in mice. On the other hand, it inhibits prolactin secretion and produces circling in unilateral 6-OHDA-lesioned rats, which is compatible with stimulant properties at dopamine D2 receptors. This drug might be a new tool to study linkage between dopamine D1 and D2 receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arnt J, Hyttel J (1985) Differential involvement of dopamine D1 and D2 receptors in the circling behaviour induced by apomorphine, SKF 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Psychopharmacology 85: 346–352

    Google Scholar 

  • Braun AR, Chase TN (1986) Obligatory D1/D2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131: 301–306

    Google Scholar 

  • Bruinvels AT, Lery H, Nozulak J, Palacios JM, Hoyer D (1992) 5-HT1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes. Naunyn Schmiedebergs Arch Pharmacol 346: 243–248

    Google Scholar 

  • Carlsson A (1978) Antipsychotic drugs, neurotransmitters and schizophrenia. Am J Psychiatry 135: 164–173

    Google Scholar 

  • Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant Ki and the concentration which caused 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099–3108

    Google Scholar 

  • Closse A, Frick W, Markstein R, Maurer R, Nordmann R (1985) [3H]205-501, a non-catechol dopaminergic agonist labels selectively and with high affinity for dopamine D2 receptors. J Neural Transm 62: 231–248

    Google Scholar 

  • Christ GJ, Jean-Jaques M (1991) Mutual-effect amplification of contractile response elicited by simultaneous activation of alpha-1 adrenergic and 5-hydroxytryptamine2 receptors in isolated rat aorta. J Pharmacol Exp Ther 256: 553–561

    Google Scholar 

  • Daly SA, Waddington JL (1992) Two directions of dopamine D/D2 receptor interaction in studies of behavioral regulation: a finding generic to four new, selective dopamine D1 receptor antagonists. Eur J Pharmacol 213: 251–258

    Google Scholar 

  • Djamgoz MBA, Wagner HJ (1992) Localization and function of dopamine in the adult vertebrate retina. Neurochem Int 20: 139–191

    Google Scholar 

  • Engel G, Hoyer D, Berthold R, Wagner H (1981) (±)[125 Iodo]cyanopindolol, a new ligand for β-adrenoceptors: Identification and quantification of subclasses of β-adrenoceptors in guinea pig. Naunyn Schmiedebergs Arch Pharmacol 317: 277–285

    Google Scholar 

  • Ford APDW, Williams TJ, Blue DR, Clarke DE (1994) α1-adrenoceptor classification: sharpening ocam's razor. Trends Pharmacol Sci 15: 167–170

    Google Scholar 

  • Fouriezos G, Hansson P, Wise RA (1978) Neuroleptic induced attenuation of brain stimulation reward in rats. J Comp Physiol Psychol 92: 661–671

    Google Scholar 

  • Frandsen EK, Krishna G (1976) A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues. Life Sci 18: 529–542

    Google Scholar 

  • Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. Handbook Exp Pharmacol 33: 283–335

    Google Scholar 

  • Göthert M, Huth H (1980) Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol 313: 21–26

    Google Scholar 

  • Hornykiewicz O (1988) Neurochemical pathology of Parkinson's disease: basic facts and hypothetical possibilities. Mt Sinai J Med 55: 11–20

    Google Scholar 

  • Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes. Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118: 13–25

    Google Scholar 

  • Hoyer D, Middlemiss DN (1989) Species differences in the pharmacology of terminal 5- HT autoreceptors in mammalian brain. Trends Pharmacol Sci 10: 130–132

    Google Scholar 

  • Hyttel J (1984) Functional evidence for selective D-1 receptor blockade by SCH 23390. Neuropharmacology 23: 1395–1401

    Google Scholar 

  • Jimerson DC (1987) Role of dopamine mechanisms in the affective disorders. In: Meltzer H (ed) Psychopharmacology. The third generation of progress. Raven Press, New York, pp 505–511

    Google Scholar 

  • Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93–96

    Google Scholar 

  • Markstein R (1986) Pharmacological characterisation of central dopamine receptors using functional criteria. In: Winlow W, Markstein R (eds) The neurobiology of dopaminergic systems. Manchester University Press, Manchester, pp 40–52

    Google Scholar 

  • Markstein R, Enz A, Vigouret JM, Jaton A, Closse A, Briner U, Gull P (1987) Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8-β-ergolene. J Neural Transm 69: 179–199

    Google Scholar 

  • McLeod RM, Lehmeyer JE (1974) Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94: 1077–1084

    Google Scholar 

  • Nordmann R, Flückiger EW, Petcher TJ, Brownell J (1988) Endocrine actions of the potent dopamine D2 agonist CV 205-502 and related octahydrobenz[g]quinolines. Drugs of the Future 13: 951–958

    Google Scholar 

  • Rogawski MA (1987) New directions in neurotransmitter action: dopamine provides some important clues. Trends Neurosci 10: 200–205

    Google Scholar 

  • Ruffolo RR, Waddell JE (1982) Receptor interactions of imidazolines: α-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists. Br J Pharmacol 77: 169–176

    Google Scholar 

  • Rüdeberg C, Urwyler S, Schulthess C, Herrling PL (1986) Biochemical and pharmacological effects of fluperlapine on noradrenaline and acetylcholine systems in some rodent, bovine and crustacean preparations. Naunyn Schmiedebergs Arch Pharmacol 332: 357–354

    Google Scholar 

  • Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32: 229–313

    Google Scholar 

  • Sibley DR, Monsma FJ (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13: 61–69

    Google Scholar 

  • Starke K (1980) Presynaptic receptors and the control of noradrenaline release. Trends Pharmacol Sci 1: 268–271

    Google Scholar 

  • Starke K, Späth JD, Adelung C (1983) Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus. Naunyn Schmiedebergs Arch Pharmacol 323: 298–306

    Google Scholar 

  • Stoof JC, Thieme RE, Vrijmoe-de Vries MC, Mulder AH (1979) In vitro acetylcholine release from rat caudate nucleus as a new model for testing drugs with dopamine receptor activity. Naunyn Schmiedebergs Arch Pharmacol 309: 119–124

    Google Scholar 

  • Taube HD, Starke K, Borowski E (1977) Presynaptic receptor systems on the noradrenergic neurones of rat brain. Naunyn Schmiedebergs Arch Pharmacol 299: 123–141

    Google Scholar 

  • Urwyler S, Markstein R (1986) Identification of dopamine D3 and D4 binding sites with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronapthalene, as high agonist affinity states of D1 and D2 dopamine receptors, respectively. J Neurochem 46: 1058–1067

    Google Scholar 

  • Vigouret JM, Buerki HR, Jaton AL, Zueger PE, Loew DM (1978) Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712. Pharmacology 16 [Suppl 1]: 156–173

    Google Scholar 

  • Waeber C, Schoeffter P, Palacios JM, Hoyer D (1988) Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain mem-branes. Naunyn Schmiedebergs Arch Pharmacol 337: 595–601

    Google Scholar 

  • Weiner RI, Ganong WF (1978) Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 58: 905–976

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Preclinical Research, Sandoz Pharma Ltd., Basle

    R. Markstein, P. Gull, A. L. Jaton, H. O. Kalkman & D. Hoyer

  2. Sandoz Research Institute Berne Ltd., Berne, Switzerland

    C. Rüdeberg, S. Urwyler & A. K. Dixon

Authors
  1. R. Markstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Gull
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Rüdeberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Urwyler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. L. Jaton
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. O. Kalkman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. K. Dixon
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D. Hoyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markstein, R., Gull, P., Rüdeberg, C. et al. SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors. J. Neural Transmission 103, 17–30 (1996). https://doi.org/10.1007/BF01292613

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01292613

Keywords

Search

Navigation